Jessica Hagen
The AI avatar, Liv, can hold conversations in real-time to provide individuals with dementia and Alzheimer's with resources and aid.
The tech giant and its partners will work to make AI-enabled eyesight-saving care more readily available to clinical systems across both countries.
The New York-based company will use the investment to grow its partnerships and coverage among payers and move into Medicare populations in 2025.
The company helps FQHCs, STD and Ryan White clinics develop, operate and grow in-house pharmacy programs focused on HIV and Hepatitis C patient populations.
The AHA and MDisrupt will also co-develop a platform to enable expert referrals and disseminate evidence-based science to healthcare technology innovators.
The company will use the funds to accelerate its product expansion on a global scale.
The Series A funding announcement comes less than a month after the company announced integration capabilities with AWS, Google Cloud, Databricks and Snowflake.
The company will use the funds to expand its partnerships with Athena, Oracle Cerner, Epic and MEDITECH, and to enhance its offerings, Suki Assistant and Suki Platform.
SPRY Therapeutics, an AI-enabled physical therapy platform, and Every Cure, an AI-powered biotech organization, also secured funds.
The acquisition allows Resilience Lab to integrate Options MD's medication management and psychotherapy offerings for individuals with severe mental illness.